loader image
Monday, October 6, 2025
97.3 F
McAllen
- Advertisement -

Epidemiology Expert Dr. Scott Lillibridge Takes Helm at DHR Health Institute for Research and Development

Translate to Spanish or other 102 languages!

DHR Health is delighted to announce Scott Lillibridge, MD, as the new Executive Vice President and Chief Executive Officer for the DHR Health Institute for Research and Development. Dr. Lillibridge brings with him a wealth of experience and expertise in global health, epidemiology, and research leadership. Courtesy Image
DHR Health is delighted to announce Scott Lillibridge, MD, as the new Executive Vice President and Chief Executive Officer for the DHR Health Institute for Research and Development. Dr. Lillibridge brings with him a wealth of experience and expertise in global health, epidemiology, and research leadership. Courtesy Image
- Advertisement -

Edinburg, Texas: DHR Health is delighted to announce Scott Lillibridge, MD, as the new Executive Vice President and Chief Executive Officer for the DHR Health Institute for Research and Development. Dr. Lillibridge brings with him a wealth of experience and expertise in global health, epidemiology, and research leadership.

“Dr. Lillibridge’s appointment to the research arm of our organization underscores our commitment to driving innovation in healthcare. His extensive experience in advancing health services to communities and dedication to the field of medicine aligns perfectly with our mission to enhance healthcare access and outcomes for citizens of the Rio Grande Valley,” said Dr. Manish Singh, DHR Health Chief Executive Officer.

Before joining DHR Health, Dr. Lillibridge served as the Associate Vice President for Global Health at Texas A&M Health Science Center. In this role, he provided leadership for multicenter research, education, and community health services, particularly in South Texas. His previous positions include Chief Scientist for the University’s Pandemic Vaccine development enterprise and Professor of Epidemiology at the Texas A&M University School of Public Health.

- Advertisement -

Dr. Lillibridge’s distinguished federal career with the Centers for Disease Control and Prevention (CDC) includes serving as Special Assistant to the Secretary for the Department of Health and Human Services, Director for the CDC Bioterrorism Preparedness and Response Program, and Medical Director for the US Office of Foreign Disaster Assistance (USAID). 

He received his B.S. in Environmental Health from East Tennessee State University, a Medical Doctorate from the Uniformed Services University of the Health Sciences, completed specialty training in Family Medicine at Baylor College of Medicine and undertook an Epidemiology Fellowship with the CDC Epidemic Intelligence Service (EIS).

“My primary goal at DHR Health is to expand the multi-disciplinary clinical research capacity and bring advanced treatment options to our community. I am glad to call the Rio Grande Valley my new home and look forward to making a positive impact on the lives of those I have the privilege to serve,” said Dr. Lillibridge. 

The DHR Health Institute for Research and Development is located at 5323 S. McColl Road in Edinburg. For questions about current research studies or clinical trials, please call the office at (956) 362-2382.

- Advertisement -
- Advertisement -

- Advertisement -

More Articles

Unidos Contra la Diabetes to Host 2026 Mini-Symposium and Annual Dia-Beat-IT Health Fair, Nov. 5th

Unidos Contra la Diabetes (UCD) has announced that its 2026 Mini-Symposium and Annual Dia-Beat-IT Health Fair is less than a month away. Moises Arjona Jr., MS, CHWI, Collective Impact Director for UCD, reminded community partners and stakeholders of the upcoming event, encouraging participation and support.

DHR Health Breast Cancer Symposium, Oct. 11th 

To support providers in the community, the DHR Health Continuing Medical Education Department will host the Breast Cancer Symposium on Saturday, October 11, at the Edinburg Conference Center at Renaissance, located at 118 Paseo del Prado.

DHR Health Introduces Advanced PSMA-PET Imaging with Illuccix® for Prostate Cancer Care

To support early and accurate detection, DHR Health now offers Illuccix (kit for the preparation of gallium Ga 68 gozetotide injection), a prostate-specific membrane antigen (PSMA) targeted positron emission tomography (PET) imaging tracer for the detection of prostate cancer.

TMA Supports Guidelines Recommending Younger Breast Cancer Screening Age

Women should begin routine annual mammography screenings at age 40, according to guidelines by the American College of Radiology and Society of Breast Imaging (ACR/SBI). Breast cancer screening guidelines vary on the initiation age for mammograms (40 versus 45 versus 50 years of age) and screening frequency (annual versus biennial).
- Advertisement -
×